National movement to bring Decision Education to K-12 students strengthened with the appointment of one of the world’s foremost experts in artificial intelligence and human decision-making.
Boston IVF, a member of the global IVI RMA Network, and one of the nation’s leading reproductive service providers and long-standing pioneer in IVF research, today announced that Chief Scientific ...
Brings deep expertise in immunology, oncology and pharmacology with a strong track record of advancing innovative pipelines through discovery and translation into the clinicReflects growing ...
CytoAgents, Inc. a clinical-stage biotechnology company developing CTO1681, a novel, steroid-sparing inhibitor of prostaglandin-mediated inflammation, announced today the appointment of Dr. Johannes ...
Venture Partner at Samsara BioCapital, and former CSO and COO of Karus Therapeutics, brings deep scientific and industry experience to Mosaic’s Executive Leadership team Stephen will lead the ...
Tolododekin alfa (ANK-101) is an anchored drug conjugate composed of interleukin-12 (IL-12) linked to aluminum hydroxide. ANK-101 enables local delivery of functional IL-12 to the tumor ...
LONDON and PHILADELPHIA, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT, "the Company", "Avacta"), a clinical stage biopharmaceutical company developing pre|CISION ® , a ...
SAN DIEGO, Jan. 06, 2026 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (VIVS) (the “Company” or “VivoSim Labs”), a pharmaceutical and biotechnology services company that is focused on providing testing of ...
BOSTON & DAEJEON, South Korea--(BUSINESS WIRE)--Orum Therapeutics (Orum or the Company) (KRX: 475830), a biotechnology company pioneering the field of degrader-antibody conjugates (DACs), today ...
This episode features Dr. Steven R. Smith, Chief Scientific Officer at AdventHealth. Here, he discusses his work with the Translational Research Institute (TRI) as it reaches its 10 year anniversary, ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min CytoAgents appointed a Chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results